NSE Symbol
ACUTAAS
This is a regulatory disclosure submitted to BSE Limited and National Stock Exchange of India Limited regarding an upcoming board meeting of Acutaas Chemicals Limited.
The Board of Directors meeting is scheduled to be held on Tuesday, October 27, 2026, at the Registered Office of the Company. The primary agenda includes consideration and approval of the Unaudited Standalone & Consolidated Financial Results for the second quarter and half year ending on September 30, 2026.
The Board Meeting will be preceded by an Audit Committee Meeting on the same day.
Regarding insider trading regulations, the disclosure confirms that the Trading Window for designated persons dealing in company shares remains closed from October 1, 2026, until 48 hours after the declaration of financial results. Specifically, the trading window will remain closed until Thursday, October 29, 2026, and will reopen on the next day. This closure was previously communicated via an intimation letter dated September 22, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
The disclosure is made pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.